An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...

California joins 23 other states eligible to receive free neffy ® (epinephrine nasal spray) at schools. SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Na ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...